Skip to main content
. Author manuscript; available in PMC: 2022 Sep 13.
Published in final edited form as: Am J Gastroenterol. 2016 Oct 11;112(1):87–94. doi: 10.1038/ajg.2016.451

Figure 2.

Figure 2

Figure 2

Kaplan-Meier plot of estimated proportion of 218 Patients who Achieved CEIM without a First Recurrence of IM or Barrett’s-associated Neoplasia by time following CE-IM. Figure 2a demonstrates overall recurrence for the cohort, while Figure 2b stratifies by segment length. Longer Prague C length was a strong risk factor for recurrence.